Home Unbiased and uncensored debate Covid-19 Lipid-lowering drug TriCor dramatically cuts treatment time for severe COVID-19

  • Lipid-lowering drug TriCor dramatically cuts treatment time for severe COVID-19

     Square-James updated 3 weeks, 1 day ago 2 Members · 2 Posts
  • Fluoxetine

    Member
    August 27, 2021 at 10:46 am

    August 23, 2021

    “The results were astounding”, shared Nahmias. “Progressive inflammation markers, that are the hallmark of deteriorative COVID-19, dropped within 48 hours of treatment. Moreover, 14 of the 15 severe patients didn’t require oxygen support within a week of treatment, while historical records show that the vast majority severe patients treated with the standard of care require lengthy respiratory support,” he added. These results are promising as TriCor (fenofibrate) was approved by the FDA in 1975 for long-term use and has a strong safety record. “There are no silver bullets”, stressed Nahmias, “but fenofibrate is far safer than other drugs proposed to date, and its mechanism of action makes is less likely to be variant-specific”.

    https://www.news-medical.net/news/20210823/Lipid-lowering-drug-TriCor-dramatically-cuts-treatment-time-for-severe-COVID-19-patients.aspx

  • Square-James

    Member
    August 31, 2021 at 3:41 pm

    I have taken Fenofibrate before. It is important to not take Fenofibrate and Statin at the same time. Severe muscle pain can occur.

    Since FLCCC already recommends statin, this would seemingly closes off the possibility for Fenofibrate.

Viewing 1 - 2 of 2 replies

Original Post
0 of 0 posts June 2018
Now